Galderma Group AG (XSWX:GALD) Accumulated Depreciation: CHF0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:GALD Galderma Group AG XSWX:GALD
16 GF Score
Price CHF178.55
! 3 Warning Signs
View Full Analysis

What is Galderma Group AG Accumulated Depreciation?

Galderma Group AG XSWX:GALD +1.45% 16 Accumulated Depreciation is CHF0 Mil as of Jun. 2026. GuruFocus rates XSWX:GALD with a GF Score™ of 16/100. The stock has 3 warning signs investors should review.

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Galderma Group AG's quarterly accumulated depreciation increased from Jun. 2025 (CHF0 Mil) to Dec. 2025 (CHF-257 Mil) but then stayed the same from Dec. 2025 (CHF-257 Mil) to Jun. 2026 (CHF0 Mil).

Galderma Group AG's annual accumulated depreciation increased from Dec. 2023 (CHF-213 Mil) to Dec. 2024 (CHF-226 Mil) and increased from Dec. 2024 (CHF-226 Mil) to Dec. 2025 (CHF-257 Mil).

Galderma Group AG Accumulated Depreciation Related Terms

Galderma Group AG Accumulated Depreciation Historical Data

* Premium members only.

The historical data trend for Galderma Group AG's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Galderma Group AG Accumulated Depreciation Chart

Galderma Group AG Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Accumulated Depreciation
0.00 0.00 -212.74 -225.58 -256.60

Galderma Group AG Semi-Annual Data
Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Accumulated Depreciation Get a 7-Day Free Trial -220.77 -225.58 0.00 -256.60 0.00
XSWX:GALD
16GF Score
Galderma Group AG XSWX:GALD
Accumulated Depreciation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Galderma Group AG Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

What does a Accumulated Depreciation of CHF0 Mil mean?
Galderma Group AG (XSWX:GALD) has a Accumulated Depreciation of CHF0 Mil as of Jun. 2026. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on Galderma Group AG and its competitors.
Is Galderma Group AG's Accumulated Depreciation too high?
Galderma Group AG's current Accumulated Depreciation is CHF0 Mil. Overall, Galderma Group AG has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Galderma Group AG's Accumulated Depreciation compare to ZTS and UTHR?
Galderma Group AG's Accumulated Depreciation of CHF0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accumulated Depreciation for a Drug Manufacturers company?
A good Accumulated Depreciation depends on the Drug Manufacturers industry context. However, Accumulated Depreciation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accumulated Depreciation mean?
A high Accumulated Depreciation can signal that a stock is expensive relative to its fundamentals. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on Galderma Group AG and its competitors. Galderma Group AG's current Accumulated Depreciation is CHF0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Galderma Group AG stock overvalued right now?
Galderma Group AG (XSWX:GALD) has a current Accumulated Depreciation of CHF0 Mil. The current Accumulated Depreciation is CHF0 Mil. Galderma Group AG's overall GF Score™ is 16/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accumulated Depreciation calculated?
Accumulated Depreciation is calculated from a company's financial statements. For Galderma Group AG (XSWX:GALD), the current Accumulated Depreciation is CHF0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Galderma Group AG Business Description

Address Zahlerweg 10, Zug, CHE, 6300
Galderma was formed in 1981 as a joint venture between Nestle and L'Oreal. It subsequently became a subsidiary of Nestle, called Nestle Skin Health, before being carved out and launched as a stand-alone company in 2019, acquired by a consortium led by Sweden-based EQT fund. The company went public in March 2024 and is listed on the SIX Swiss exchange. Galderma's science-based portfolio spans multiple dermatology categories, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. It derives around 40% of net sales from the US and employs more than 7,500 people.
16GF Score

Get the complete analysis for XSWX:GALD

Accumulated Depreciation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF178.55
Price